(Stroke. 2002;33:998.)
© 2002 American Heart Association, Inc.
Original Contributions |
From the Department of Neurology (S. Schwarz, D.G., S. Schwab) and Neurosurgery (A.A.), University of Heidelberg, Heidelberg, Germany.
Correspondence to Dr. Stefan Schwarz, Department of Neurology, University of Heidelberg, 400 Im Neuenheimer Feld, Heidelberg 69120, Germany. E-mail stefan_schwarz{at}med.uni-heidelberg.de
Background and Purpose Our aim was to prospectively evaluate the effects of induced arterial hypertension in patients with large ischemic stroke.
Methods A total of 47 monitoring sessions in 19 patients with acute, complete, or subtotal middle cerebral artery (MCA) territory stroke were performed. Intracranial pressure (ICP) was monitored using a parenchymal catheter. Mean arterial blood pressure (MAP), ICP, and peak mean flow velocity of the middle cerebral arteries (VmMCA) were continuously recorded. Patients with acute ICP crises were excluded. After obtaining baseline values, MAP was raised by an infusion of norepinephrine to reach an MAP increase of at least 10 mm Hg. After MAP had reached a peak plateau level, the norepinephrine infusion was stopped.
Results Baseline MAP was 83.6±1.6 mm Hg and rose to 108.9±2.0 mm Hg after infusion of norepinephrine. ICP slightly increased from 11.6±0.9 mm Hg to 11.8±0.9 mm Hg (P<0.05). Cerebral perfusion pressure rose from baseline 72.2±2 mm Hg to 97±1 mm Hg (P<0.0001). VmMCA was already higher on the affected side during baseline measurements. At maximum MAP levels, VmMCA rose by 25.5±5.5 cm/s on the affected side and by 8.6±1.6cm/s on the contralateral side.
Conclusions In patients with large hemispheric stroke without an acute ICP crisis, induced hypertension enhances cerebral perfusion pressure and augments the VmMCA(s), more so on the affected side. The ICP slightly increases; however, this is probably not clinically significant.
Key Words: blood flow velocity cerebral perfusion pressure hypertension intracranial pressure norepinephrine stroke
This article has been cited by other articles:
![]() |
H. K. Shin, M. Nishimura, P. B. Jones, H. Ay, D. A. Boas, M. A. Moskowitz, and C. Ayata Mild Induced Hypertension Improves Blood Flow and Oxygen Metabolism in Transient Focal Cerebral Ischemia Stroke, May 1, 2008; 39(5): 1548 - 1555. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. F. A. Jansen, A. Krins, B. Basnyat, J. A. Odoom, and C. Ince Role of the altitude level on cerebral autoregulation in residents at high altitude J Appl Physiol, August 1, 2007; 103(2): 518 - 523. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. K. Mistri, T. G. Robinson, and J. F. Potter Pressor Therapy in Acute Ischemic Stroke: Systematic Review Stroke, June 1, 2006; 37(6): 1565 - 1571. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. V. Immink, G. A. van Montfrans, J. Stam, J. M. Karemaker, M. Diamant, and J. J. van Lieshout Dynamic Cerebral Autoregulation in Acute Lacunar and Middle Cerebral Artery Territory Ischemic Stroke Stroke, December 1, 2005; 36(12): 2595 - 2600. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. V. Immink, B.-J. H. van den Born, G. A. van Montfrans, R. P. Koopmans, J. M. Karemaker, and J. J. van Lieshout Impaired Cerebral Autoregulation in Patients With Malignant Hypertension Circulation, October 12, 2004; 110(15): 2241 - 2245. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. S. Marzan, H. -J. Hungerbuhler, A. Studer, R. W. Baumgartner, and D. Georgiadis Feasibility and safety of norepinephrine-induced arterial hypertension in acute ischemic stroke Neurology, April 13, 2004; 62(7): 1193 - 1195. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. F. Hanley Review of Critical Care and Emergency Approaches to Stroke Stroke, February 1, 2003; 34(2): 362 - 364. [Full Text] [PDF] |
||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2002 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |